BetterLife Pharma Names Peter Goadsby Co — Chair of Scientific Advisory Board
BetterLife Pharma formed a scientific advisory board, appointing Professor Peter Goadsby co-chair. The board will guide BETR-001 clinical development for chronic cluster headache and chronic migraine. Goadsby previously held faculty positions at University College London and the University of California, San Francisco.